FDA Inspection
Medisca, Inc.Medisca, Inc. – FDA Inspection, Dec 8, 2017
Record Details
This FDA Inspection record concerns Medisca, Inc., with an inspection on December 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · be16bb5e-9689-49dd-b1fb-2dd0185255be
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1035252
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medisca, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2025 | Not classified | New York District Office | |
| October 6, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2019 | Not classified | New York District Office | |
| April 7, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 27, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medisca, Inc.
- FDA Inspection 1293350 - 2025-11-20
- FDA Inspection 1132253 - 2020-10-06
- FDA Inspection 1087260 - 2019-04-16
- FDA Inspection 967422 - 2016-04-07
- FDA Inspection 867865 - 2014-02-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.